Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Am J Surg Pathol. 2022 Nov 3;47(2):270–277. doi: 10.1097/PAS.0000000000001997

Table 1.

Clinical Summary

Case Age (years) Sex Primary Site Size (cm) Presentation Treatment Status at last follow-up Follow-up period (months)
1 67 Male Right shoulder infiltrative mass involving soft tissue, bone and lung 7.8 Infiltrative shoulder mass Marginal resection, subsequent wide resection (close margin) of local recurrence, gemcitabine/docetaxel × 3 months-->pazopanib × 2 months-->doxorubicin/olaratumab × 7 cycles-->pebrolizumab--->bevacizumab DOD (distant lung, spine, pelvic metastases) 36
2 63 Female Left superoposterior chest wall deep to trapezius muscle 7.0 Left shoulder mass with gradual increase in size over 1 year Radical resection ANED 9
3 75 Female Left posterior thigh 9.1 Cough and fatigue for 3 months. CT scan reveals lung and mediastinal masses Radiation to lung, doxil × 3 months, pazopanib DOD (distant lung, pleural/mediastinal metastases) 5

ANED: alive with no evidence of disease; DOD: dead of disease.